We also examined the levels of inflammatory markers (TNF-α and IL-6), which were selected to assess systemic and hepatic inflammation, as both are known to play significant roles in the pathophysiology of obesity and NAFLD. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.